Itchy Skin: A Challenging Differential Diagnosis Between Mycosis Fungoides and Sezary Syndrome

被引:0
|
作者
Rocha, Claudia Abreu [1 ]
Borges, Margarida Drummond [1 ]
Santos, Guida Maria [2 ]
Sousa, Miriam [3 ]
Teixeira, Tania [1 ]
机构
[1] Ctr Saude Machico, Serv Saude da Regiao Autonoma da Madeira SESARAM, Family Med, Madeira Isl, Portugal
[2] Ctr Saude Canico, Serv Saude da Regiao Autonoma da Madeira SESARAM, Family Med, Madeira Isl, Portugal
[3] Hosp Cent Funchal, Pathol, Madeira Isl, Portugal
关键词
mycosis fungoidis; cutaneous t cell lymphoma; generalized rash; sezary syndrome; pruritus; LYMPHOMA TASK-FORCE; EUROPEAN-ORGANIZATION; CLASSIFICATION; CRITERIA;
D O I
10.7759/cureus.46427
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Primary cutaneous lymphomas represent a diverse spectrum of T-cell and B-cell lymphomas with their primary skin manifestation. Among these, mycosis fungoides (MF) and Sezary syndrome (SS) represent classic forms of cutaneous T-cell lymphomas (CTCLs). This report details the case of a 67-year-old female who presented with longstanding pruritic skin lesions, initially misdiagnosed and managed as eczema. The diagnostic process ultimately revealed the presence of Sezary cells in the peripheral blood smear (PBS). The SS diagnosis was confirmed based on CD4 positivity and CD7 negativity as determined by flow cytometry. The disease was staged as IVA1 (T2N0M1B2). The patient exhibited partial improvement with oral corticosteroid therapy. This report underscores the critical importance of integrating clinical evaluation and blood findings to distinguish between MF and SS. The progression of a circulating clone signals a poor prognosis, requiring surveillance and consideration of targeted therapies to enhance patient outcomes and improve their quality of life. Early detection remains paramount in the management of these rare cutaneous lymphomas, which are associated with unique therapeutic challenges.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Multidisciplinary Management of Mycosis Fungoides/Sezary Syndrome
    Berg, Sara
    Villasenor-Park, Jennifer
    Haun, Paul
    Kim, Ellen J.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2017, 12 (03) : 234 - 243
  • [22] Bexarotene therapy for mycosis fungoides and Sezary syndrome
    Abbott, R. A.
    Whittaker, S. J.
    Morris, S. L.
    Russell-Jones, R.
    Hung, T.
    Bashir, S. J.
    Scarisbrick, J. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2009, 160 (06) : 1299 - 1307
  • [23] The biomarker landscape in mycosis fungoides and Sezary syndrome
    Dulmage, Brittany
    Geskin, Larisa
    Guitart, Joan
    Akilov, Oleg E.
    EXPERIMENTAL DERMATOLOGY, 2017, 26 (08) : 668 - 676
  • [24] Is smoking associated with mycosis fungoides and Sezary syndrome?
    Chang, H. -C.
    Tsai, T. -Y.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (05) : E381 - E384
  • [25] Mycosis fungoides and Sezary syndrome - Review and outlook
    Latzka, Johanna
    Trautinger, Franz
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 (04): : 391 - 392
  • [26] TOX Expression in Mycosis Fungoides and Sezary Syndrome
    Pileri, Alessandro
    Cavicchi, Martina
    Bertuzzi, Clara
    Righi, Simona
    Zengarini, Corrado
    Sabattini, Elena
    Roncador, Giovanna
    Agostinelli, Claudio
    DIAGNOSTICS, 2022, 12 (07)
  • [27] MYCOSIS-FUNGOIDES AND THE SEZARY-SYNDROME
    GISSELBRECHT, C
    DUBERTRET, L
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1993, 35 (01): : 73 - 75
  • [29] Tumor microenvironment in mycosis fungoides and Sezary syndrome
    Gonzalez, Belen Rubio
    Zain, Jasmine
    Rosen, Steven T.
    Querfeld, Christiane
    CURRENT OPINION IN ONCOLOGY, 2016, 28 (01) : 88 - 96
  • [30] The utility of bexarotene in mycosis fungoides and Sezary syndrome
    Panchal, Manisha R.
    Scarisbrick, Julia J.
    ONCOTARGETS AND THERAPY, 2015, 8 : 367 - 373